Relmada Therapeutics, Inc. (RLMD)

7.03 +0.69 (+10.88%) USD  |  NASDAQ  |  May 19, 16:00
7.03 0.00 (0.00%) After-Hours: 07:11
More

Relmada Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Theravance Biopharma, Inc. Upgrade
AN2 Therapeutics, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
Johnson & Johnson Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade